Skip to content
LifeSci_Capital_2C_solid
  • Home
  • Expertise
    • Equity Research
    • Investment Banking
    • Equity Capital Markets
  • Team
  • LifeSci Platform
  • Careers
  • Contact
  • Home
  • Expertise
    • Equity Research
    • Investment Banking
    • Equity Capital Markets
  • Team
  • LifeSci Platform
  • Careers
  • Contact Us

Abivax

By Chase Oswald | March 7, 2023
Read More

Vera Therapeutics

By Chase Oswald | February 10, 2023
Read More

Astria Therapeutics

By Chase Oswald | December 30, 2022
Read More

Immunovant

By Chase Oswald | October 12, 2022
Read More

Allakos

By Chase Oswald | September 20, 2022
Read More

Larimar Therapeutics

By Chase Oswald | September 20, 2022
Read More

Abivax

By Chase Oswald | September 10, 2022
Read More

Viridian Therapeutics

By Chase Oswald | August 22, 2022
Read More

CinCor Pharma

By Chase Oswald | August 16, 2022
Read More

BELLUS Health

By Chase Oswald | July 19, 2022
Read More
Older Posts »
logo-color

LifeSci Capital is a boutique investment bank focused solely on emerging Life Science and Healthcare companies.

  • Home
  • Team
  • LifeSci Platform
  • Careers
  • Contact Us

Headquarters

250 West 55th Street, Suite 3401

New York, NY 10019

+1 646 889 1200

info@lifescicapital.com

© 2023 LifeSci Capital. Business Continuity Plan  |  CIP Notification  |  Member: SIPC / FINRA  |  LSC CRS  |  Disclosure 605 & 606 Reporting